BL-RTA-1 30mg
All Tests PassLab: Freedom Diagnostics
In Stock
Best Seller
BL-RTA-1
30mg|Freedom Diagnostics
COA with every batch
Limited Quantity
Triple Receptor Activation
BL-RTA-1 is a focus for researchers studying convergent metabolic signaling. As a triple agonist, it simultaneously engages the GLP-1, GIP, and glucagon receptors, providing a unique model for examining how three distinct pathways interact within a single molecular framework. Studies use BL-RTA-1 to investigate the combined receptor dynamics that distinguish it from single or dual incretin agonists in metabolic models.
Energy Expenditure & Glucagon Signaling
In metabolic research, BL-RTA-1 is investigated for the glucagon-receptor component of its activity. Researchers study how glucagon engagement increases basal energy expenditure and influences substrate oxidation, examining the contribution of this third pathway to overall metabolic output in preclinical models.
Incretin Synergy & Adipose Regulation
Recent studies have utilized BL-RTA-1 to investigate the combined incretin effects on insulin sensitivity and adipose signaling. By examining how GLP-1 and GIP engagement work alongside glucagon activation, researchers explore the peptide's role in body-composition and energy-balance research frameworks.
For research use only.
BL-RTA-1 is a synthetic peptide widely studied for its triple-agonist activity, simultaneously targeting the GLP-1, GIP, and glucagon receptors to investigate integrated metabolic signaling.
Yes. BL-RTA-1 is a synthetic peptide commonly investigated in preclinical research involving metabolic regulation, incretin biology, and energy homeostasis.
BL-RTA-1 is commonly investigated in studies involving GLP-1, GIP, and glucagon receptor signaling, energy expenditure, substrate utilization, insulin sensitivity, adipose biology, body composition, and metabolic regulation.
BL-RTA-1 should be stored in a cool, dry environment. For long-term stability, lyophilized vials are typically kept frozen and protected from heat, moisture, and direct sunlight.
BL-RTA-1 is unique because it simultaneously activates the GLP-1, GIP, and glucagon receptors, enabling researchers to study the combined effects of triple-receptor signaling on energy expenditure, metabolic flexibility, and body composition within a single molecular framework.
Overview
Triple Receptor Activation
BL-RTA-1 is a focus for researchers studying convergent metabolic signaling. As a triple agonist, it simultaneously engages the GLP-1, GIP, and glucagon receptors, providing a unique model for examining how three distinct pathways interact within a single molecular framework. Studies use BL-RTA-1 to investigate the combined receptor dynamics that distinguish it from single or dual incretin agonists in metabolic models.
Energy Expenditure & Glucagon Signaling
In metabolic research, BL-RTA-1 is investigated for the glucagon-receptor component of its activity. Researchers study how glucagon engagement increases basal energy expenditure and influences substrate oxidation, examining the contribution of this third pathway to overall metabolic output in preclinical models.
Incretin Synergy & Adipose Regulation
Recent studies have utilized BL-RTA-1 to investigate the combined incretin effects on insulin sensitivity and adipose signaling. By examining how GLP-1 and GIP engagement work alongside glucagon activation, researchers explore the peptide's role in body-composition and energy-balance research frameworks.
For research use only.
Storage
To preserve research integrity, store unopened lyophilized vials:
- Store at -20°C for long-term preservation.
- Short-term storage at 2–8°C is acceptable before use.
- Protect from heat, moisture, and direct sunlight.
- Keep the vial tightly sealed until needed.
- Avoid repeated freeze-thaw cycles after reconstitution.
- Handle using standard laboratory procedures.
Trusted by 150+ Customers
60-day money-back guaranteeon every order
